Skip to main content
. 2020 Jan 31;2020:7023420. doi: 10.1155/2020/7023420

Table 1.

Baseline characteristics and clinical features of TCM group and the control group before and after PSM.

Group Before PSM After PSM
TCM n = 285 Control n = 244 p value TCM n = 175 Control n = 175 p value
Gender
 Male 170 (59.6) 147 (60.2) 0.889 106 (60.6) 102 (58.3) 0.663
 Female 115 (40.4) 97 (39.8) 69 (39.4) 73 (41.7)
Pathology
 None 16 (5.6) 9 (3.7) 0.247 11 (6.3) 8 (4.6) 0.510
 Adenocarcinoma 259 (90.9) 226 (92.6) 160 (91.4) 159 (90.9)
 Squamous cell Ca 1 (0.4) 4 (1.6) 1 (0.6) 4 (2.3)
 Others 9 (3.2) 5 (2.0) 3 (1.7) 4 (2.3)
Stage
 I 17 (6.0) 24 (9.8) <0.001 14 (8.0) 10 (5.7) 0.538
 II 58 (20.4) 93 (38.1) 44 (25.1) 57 (32.6)
 III 90 (31.6) 71 (29.1) 66 (37.7) 60 (34.3)
 IV 120 (42.1) 56 (23.0) 51 (29.1) 48 (27.4)
Histodifferentiation
 Unknown 40 (14.0) 18 (7.4) 0.005 21 (12.0) 16 (9.1) 0.460
 Low 14 (4.9) 8 (3.3) 3 (1.7) 8 (4.6)
 Moderate 179 (62.8) 151 (61.9) 110 (62.9) 97 (55.4)
 Moderate-low 16 (5.6) 47 (19.3) 11 (6.3) 35 (20.0)
 Moderate-high 36 (12.6) 20 (8.2) 30 (17.1) 19 (10.9)
Location
 Rectum 115 (40.4) 45 (18.4) <0.001 43 (24.6) 43 (24.6) 1
 Colon 170 (59.6) 199 (81.6) 132 (75.4) 132 (75.4)
Surgery
 Yes 258 (90.5) 224 (91.8) 0.607 158 (90.3) 160 (91.4) 0.711
 No 27 (9.5) 20 (8.2) 17 (9.7) 15 (8.6)
Chemotherapy
 Yes 221 (77.5) 198 (81.1) 0.309 143 (81.7) 145 (82.9) 0.779
 No 64 (22.5) 46 (18.9) 32 (18.3) 30 (17.1)
Hypertension
 Yes 79 (27.7) 81 (33.2) 0.172 53 (30.3) 50 (28.6) 0.725
 No 206 (72.3) 163 (66.8) 122 (69.7) 125 (71.4)
Diabetes
 Yes 75 (26.3) 65 (26.6) 0.933 47 (26.9) 32 (18.3) 0.055
 No 210 (73.7) 179 (73.4) 128 (73.1) 143 (81.7)
Smoking
 Yes 122 (42.8) 60 (24.6) <0.001 56 (32.0) 54 (30.9) 0.818
 No 163 (57.2) 184 (75.4) 119 (68.0) 121 (69.1)
Drinking
 Yes 68 (23.9) 55 (22.5) 0.720 35 (20.0) 36 (20.6) 0.894
 No 217 (76.1) 189 (77.5) 140 (80.0) 139 (79.4)
Intestinal obstruction
 Yes 33 (11.6) 45 (18.4) 0.026 23 (13.1) 31 (17.7) 0.236
 No 252 (88.4) 199 (81.6) 152 (86.9) 144 (82.3)
Family history
 Yes 89 (31.2) 58 (23.8) 0.056 50 (28.6) 47 (26.9) 0.720
 No 196 (68.8) 186 (76.2) 125 (71.4) 128 (73.1)
Age
 >60 220 (77.2) 204 (83.6) 0.065 146 (83.4) 140 (80.0) 0.407
 ≤60 65 (22.8) 40 (16.4) 29 (16.6) 35 (20.0)

PSM: propensity scores matching; p < 0.05, there was a significant statistical difference in the subgroup.